Profiel
Robert Berman was the founder of Biohaven Pharmaceuticals, Inc., which was founded in 2013, where he held the title of Chief Medical Officer from 2013 to 2019.
Currently, he is an Independent Director at Social Capital Suvretta Holdings Corp.
II, where he started in 2022.
Dr. Berman received his undergraduate degree from Yale University and another undergraduate degree from Icahn School of Medicine at Mount Sinai in 1990.
Actieve functies van Robert Berman
| Bedrijven | Functie | Begin |
|---|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Directeur/Bestuurslid | 29-06-2022 |
Eerdere bekende functies van Robert Berman
| Bedrijven | Functie | Einde |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Oprichter | 01-01-2019 |
Opleiding van Robert Berman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Commercial Services |
Social Capital Suvretta Holdings Corp. II
Social Capital Suvretta Holdings Corp. II Financial ConglomeratesFinance Operates as blank check company | Finance |
















